Measured Wealth Private Client Group LLC purchased a new stake in shares of Cabot Co. (NYSE:CBT – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,250 shares of the specialty chemicals company’s stock, valued at approximately $205,000.
Other institutional investors have also added to or reduced their stakes in the company. Copeland Capital Management LLC raised its stake in shares of Cabot by 21.6% during the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock valued at $69,521,000 after acquiring an additional 135,119 shares during the last quarter. R Squared Ltd bought a new position in Cabot during the 4th quarter valued at approximately $26,000. Foundations Investment Advisors LLC lifted its holdings in Cabot by 28.7% in the 4th quarter. Foundations Investment Advisors LLC now owns 2,573 shares of the specialty chemicals company’s stock worth $235,000 after buying an additional 573 shares during the period. Pacer Advisors Inc. grew its position in shares of Cabot by 14.5% in the 4th quarter. Pacer Advisors Inc. now owns 16,351 shares of the specialty chemicals company’s stock worth $1,493,000 after buying an additional 2,069 shares during the last quarter. Finally, KBC Group NV increased its stake in shares of Cabot by 43.1% during the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock valued at $187,000 after buying an additional 616 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Insider Buying and Selling at Cabot
In other Cabot news, CAO Lisa M. Dumont sold 865 shares of Cabot stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total value of $96,655.10. Following the completion of the transaction, the chief accounting officer now directly owns 9,742 shares of the company’s stock, valued at approximately $1,088,571.08. The trade was a 8.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Jeff Ji Zhu sold 14,566 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $113.25, for a total transaction of $1,649,599.50. Following the sale, the executive vice president now owns 69,449 shares in the company, valued at approximately $7,865,099.25. The trade was a 17.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,190 shares of company stock worth $5,751,534. 3.03% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
View Our Latest Research Report on Cabot
Cabot Price Performance
Shares of CBT stock opened at $86.17 on Friday. The company has a quick ratio of 1.36, a current ratio of 2.08 and a debt-to-equity ratio of 0.68. The stock has a market cap of $4.67 billion, a price-to-earnings ratio of 12.78, a PEG ratio of 0.74 and a beta of 1.19. The business’s fifty day moving average is $93.48 and its 200 day moving average is $101.71. Cabot Co. has a twelve month low of $77.21 and a twelve month high of $117.46.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 9.51% and a return on equity of 26.60%. Research analysts expect that Cabot Co. will post 7.67 EPS for the current fiscal year.
Cabot announced that its board has approved a stock repurchase plan on Tuesday, December 3rd that allows the company to buyback 10,000,000 outstanding shares. This buyback authorization allows the specialty chemicals company to purchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its stock is undervalued.
Cabot Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend is Friday, February 28th. Cabot’s dividend payout ratio (DPR) is presently 22.84%.
Cabot Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- How to Buy Cheap Stocks Step by Step
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How Investors Can Find the Best Cheap Dividend Stocks
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.